Work Here?
Kyowa Kirin
Work Here?
Global specialty pharma leveraging fermentation and antibodies
Kyowa Kirin
Work Here?
Global specialty pharma leveraging fermentation and antibodies
About Kyowa Kirin
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Tokyo, Japan
Founded
1885
Overview
Kyowa Kirin is a global specialty pharmaceutical company that develops medicines using fermentation and antibody technologies. Its products target areas like nephrology, oncology, and immunology, with therapies built from biologics and other drug modalities. The company emerged from a merger between Kyowa Hakko Kogyo and Kirin Pharma, combining Kyowa’s fermentation and microbiology expertise with Kirin’s pharma resources to create a worldwide focus on specialty drugs. Unlike broader drug companies, Kyowa Kirin concentrates on a defined set of indications and runs a research-and-development-led business that aims to deliver innovative treatments for patients in need.
Simplify's Take
What believers are saying
- Libmeldy commercialization in MLD expands rare disease revenue streams globally.
- Orchard pipeline programs in MPS, FTD, Crohn's disease address high unmet needs.
- North Carolina manufacturing capacity supports cell and gene therapy market growth.
What critics are saying
- Libmeldy reimbursement denial in UK, Germany, US collapses primary revenue driver.
- Orchard pipeline failures in Phase 2/3 trials eliminate $478M acquisition rationale.
- Gene therapy manufacturing delays at Sanford facility constrain supply and revenue ramp.
What makes Kyowa Kirin unique
- 75+ years fermentation expertise underpins proprietary antibody and gene therapy platforms.
- Orchard Therapeutics acquisition adds Libmeldy gene therapy for rare genetic diseases.
- $530M Sanford biologics facility enables scaled manufacturing of advanced cell therapies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
401(k) Company Match
Paid Vacation
Paid Sick Leave
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Hybrid Work Options
Pet Insurance
Tuition Assistance
Stock Price
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↓ -1%2 year growth
↓ -1%Link Cell Therapies has emerged from stealth with $60 million in Series A funding led by Johnson & Johnson Innovation – JJDC, bringing total capital raised to $92 million. The South San Francisco–based oncology company is developing CAR-T therapies for solid and liquid tumours using proprietary logic-gating technology. The platform enables safe targeting of multiple antigens co-expressed on cancer cells whilst sparing healthy tissue. Co-founded by Dr Robbie Majzner and Dr Crystal Mackall at Stanford University in 2022, Link's lead programme, LNK001 for renal cell carcinoma, is on track for an IND application and Phase I trial in 2026. The Series A round included participation from founding investors Samsara BioCapital and Sheatree Capital, alongside new backers Bristol Myers Squibb, Kyowa Kirin and Wing Venture Capital.
Garuda Therapeutics, a Cambridge, MA-based hematopoietic stem cell (HSC) therapies company, raised $50M in Series A-1 funding
The partnership combines Cimeio's proprietary Shielded Cell and Immunotherapy (SCIP) platform with Kyowa Kirin's expertise in cellular therapies and underscores both companies' commitment to using emerging cell and gene therapy technologies to develop new ways to treat patients.
Kyowa Kirin, a Japanese global specialty pharmaceutical company, plans to invest more than $200 million in Sanford to build its first pharmaceutical manufacturing complex in North America, adding more than 100 new jobs.
Japan-based Kyowa Kirin has unveiled its plans to invest $530m to build a new advanced biologics manufacturing facility in Sanford in the American state of North Carolina.
Kyowa Kirin is Hiring for 25 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Kyowa Kirin
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Tokyo, Japan
Founded
1885
Kyowa Kirin is Hiring for 25 Jobs on Simplify!
Find jobs on Simplify and start your career today